Li G Z
Shanxi Tumour Hospital, Taiyuan.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1993;28(3):170-3, 188.
A prospective study on the therapeutic effect of either preoperative radiotherapy and operation (101 cases) or operation alone (159 cases) by random grouping for a total of 260 patients with laryngocarcinoma were conducted. By analysing the survival curve and time schedule test, we compared the population survival rate, clinical typing, T classification, staging, pathological grading, operative method and infection rate between the two groups. The result shows that there is no significant difference between survival curves. It is indicated that the preoperative radiotherapy can increase neither the five-year survival rate nor the postoperative infection rate evidently, but it may increase the survival rates of those with poorly differentiated squamous carcinoma (grade III or IV), those in advanced stage carcinoma (T3 or T4 stage IV) or those who will undergo extensive laryngectomy. The three-year and five-year survival rates were 75.4% and 67.5% respectively; for the glottic type the rates were 78.4% and 71.0%; 73.7% and 64.5% for the supraglottic type; 76.1% and 72.3% for the partial laryngectomy; and 71.4% and 53.9% for the total laryngectomy.
对260例喉癌患者进行前瞻性研究,随机分组比较术前放疗加手术(101例)与单纯手术(159例)的治疗效果。通过分析生存曲线和时序检验,比较两组的总体生存率、临床分型、T分级、分期、病理分级、手术方式及感染率。结果显示,两组生存曲线无显著差异。表明术前放疗既不能明显提高五年生存率,也不能明显提高术后感染率,但可提高低分化鳞癌(Ⅲ级或Ⅳ级)、晚期癌(T3或T4 Ⅳ期)或行广泛喉切除术患者的生存率。三年和五年生存率分别为75.4%和67.5%;声门型分别为78.4%和71.0%;声门上型分别为73.7%和64.5%;部分喉切除术分别为76.1%和72.3%;全喉切除术分别为71.4%和53.9%。